David Sidransky
InvestorCo-Founder and Managing Partner at Israel Biotech Fund
Pikesville, Maryland, United States
Contact· self-published, not guessed
Experience
- Johns Hopkins UniversityProfessorcurrent1988 — present
- Champions Oncology, Inc.Member Board of Directorscurrent2016 — present
- Champions Oncology, Inc.Chairman of the Board2008 — 2016
- Galmed Pharmaceuticals Ltd.Board Membercurrent2014 — present
- Ayala PharmaceuticalsChairman of the Board2019 — 2025
- Advaxis, Inc.Chairman of the Board2013 — 2024
- Orgenesis Inc.Member Board of Directors2013 — 2024
- Tamir BiotechnologyChairman of the Board2007 — 2020
- Rosetta GenomicsMember of the Board of Directors2009 — 2017
- Celsus Therapeutics PLCMember of the Board of Directors2012 — 2015
- KV PharmaceuticalDirector2010 — 2012St louis MO
- Maimonides Academy of BaltimoreChairman of the Board2008 — 2010
- Teva Pharmaceuticalsconsultant2007 — 2010
- ImClone Systems, a wholly-owned subsidiary of Eli Lilly and CompanyMember of the Board of Directors2005 — 2009
- ImClone Systems, a wholly-owned subsidiary of Eli Lilly and CompanyVice chairman of the board2005 — 2008
- American Association for Cancer Researchdirector2006 — 2008
Skills & more
Oncology82Urology26Genetics42Lifesciences32Biotechnology59Drug Discovery25Molecular Biology28Cancer34Clinical Trials24Cell Biology15Clinical Development18Life Sciences48
+12 more
Clinical ResearchImmunologyProtein ChemistryGenomicsStart-upsDrug DevelopmentBiochemistryTechnology TransferPharmaceutical IndustryCell CultureMedicineDue DiligenceFrom David's professional profile.
Deals · 5
AdvaxisBoard seat
via Israel Biotech Fund · filed Nov 2023 · $433.8K raise
Galmed PharmaceuticalsBoard seat
via Israel Biotech Fund · filed Aug 2017 · $350K raise
OrgenesisBoard seat
via Israel Biotech Fund · filed Dec 2015 · $10M raise
Tamir BiotechnologyBoard seat
via Israel Biotech Fund · filed Sep 2015 · $800K raise
Champions OncologyBoard seat
via Israel Biotech Fund · filed Mar 2015 · $14M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Israel Biotech Fund
Frequently asked questions
- Who is David Sidransky?
- Co-Founder and Managing Partner at Israel Biotech Fund
- Where does David Sidransky work?
- David Sidransky is Co-Founder and Managing Partner at Israel Biotech Fund.
- What boards does David Sidransky sit on?
- David Sidransky holds tracked board seats at Advaxis, Advaxis, Champions Oncology, Galmed Pharmaceuticals, Orgenesis, Tamir Biotechnology.
- Where did David Sidransky go to school?
- David Sidransky studied at Baylor College of Medicine (md, internal medicine); Brandeis University (bs, chemistry).
Same school
Also attended Baylor College of Medicine19
Nessan BerminghamInvestor at Khosla VenturesLucy LiuPrincipal at Longwood FundJonathan MercadoPrincipal at First Bight VenturesCollin McCollAnalyst at First Bight VenturesPhil SangerManaging Partner at TEXO VenturesFarzad SoleimaniPartner at 1984 Ventures Management, Llc
+ 13 more
Also attended Brandeis University65
Santiago ReganDirector of Business Development at Redpoint VenturesNicholas AdamsManaging Partner at Differential VenturesJohn KeiltyVenture Partner at Third Rock VenturesKevin GillisPartner and Chief Operating Officer at Third Rock VenturesSeth LieblichInvestment Team at 8VCAlex MorganInvestor at Khosla Ventures
+ 59 more
Shared employers
Also worked at Johns Hopkins University57
Demi ObayomiPrincipal at Sapphire VenturesJun JeonInvestor at Khosla VenturesLinda CuretonBoard Member at Maryland TEDCODavid NarrowVenture Advisor at Cultivation CapitalCharlie BuffaVice President, Sales at Mainsail PartnersOluwakayode (Kay) JasanyaInvestor at SUPPLY CHANGE CAPITAL
+ 51 more
Also worked at Champions Oncology, Inc.1
Also worked at Teva Pharmaceuticals23
Catherine Pearce, DHSc, MBAAdvisor at CincyTechElad BaronInvestment Professional at Key1 CapitalElaine ShannonPresident, Global Supply & Quality at Takeda VenturesRiki MozesVice President, Chief People Officer at Jerusalem Venture Partners (JVP)Jill DeSimoneDigital Pharma Advisor at Excelerate Health VenturesPerry NisenExecutive Advisor, Private Equity at Sofinnova Ventures
+ 17 more
